Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4106139 Target Snapshot

GroEL/GroES · PROTEIN COMPLEX · Escherichia coli

368Compounds
25Assays
21Approved Drugs
738.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q548M1. Use UniProt Q548M1 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q548M1 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats GroEL/GroES as ChEMBL target CHEMBL4106139, mapped to UniProt Q548M1. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
GroEL/GroES
PROTEIN COMPLEX · Escherichia coli
As of 2026-09-13
ChEMBL target ID
CHEMBL4106139
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q548M1
Chaperonin GroEL
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether GroEL/GroES is the right protein anchor across sources, using UniProt Q548M1 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelChaperonin GroEL
UniProt AccessionQ548M1
Component TypeProtein
Sequence Length548 aa

Chaperonin GroEL

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as GroEL/GroES, mapped to UniProt Q548M1. ChEMBL maps the protein component as Chaperonin GroEL. Sequence length is 548 aa.

Mapped IDQ548M1
Review nameGroEL/GroES
OrganismEscherichia coli
Clinical Profile

Clinical Phase Distribution

21
Approved
5
Phase III
6
Phase II
1
Phase I
Assay Mix

Activity Type Distribution

IC50738.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1200712 7.41 IC50 39.0 Approved
CHEMBL3115908 7.22 IC50 60.0 Preclinical
CHEMBL3986320 6.64 IC50 230.0 Preclinical
CHEMBL3115913 6.6 IC50 250.0 Preclinical
CHEMBL295316 6.54 IC50 290.0 Preclinical
CHEMBL297453 6.44 IC50 360.0 Clinical
CHEMBL253570 6.41 IC50 390.0 Preclinical
CHEMBL1516388 6.37 IC50 430.0 Preclinical
CHEMBL3115909 6.36 IC50 440.0 Preclinical
CHEMBL704 6.31 IC50 490.0 Approved
Distribution

pChEMBL Value Distribution

93
5.0
68
5.5
31
6.0
5
6.5
3
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

MESALAMINE
CHEMBL704
Approved 1987
RIBOFLAVIN 5'-PHOSPHATE SODIUM
CHEMBL3989697
Approved 1985
EVANS BLUE
CHEMBL1200712
Approved 1982
TANNIC ACID
CHEMBL506247
Approved 1982
Assay Landscape

Assay Landscape

25
Total Assays
261
Tested Compounds
1
Assay Types
Binding — 25 assays, 261 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 14 209 5.0
protein complex format 6 31 4.8
cell-based format 5 21 5.3

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine